White label ELPA - ClinicalTrials.eu

Study on Setanaxib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Not recruiting

2 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
- Setanaxib
- Pembrolizumab
Study of Long-term Safety and Efficacy of Fitusiran in Patients with Hemophilia A or B with or without Inhibitory Antibodies to Factor VIII or IX

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemophilia
Investigated Drugs:
Study on Trastuzumab Deruxtecan, Trastuzumab, and Pertuzumab for Patients with HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- HER2 positive breast cancer
Investigated Drugs:
Study on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis

Not recruiting

3 1 1
Investigated Drugs:
- Abrocitinib
Study on the Effects of Baricitinib in Early-Stage Rheumatoid Arthritis

Not recruiting

2 1 1
Investigated Drugs:
- Baricitinib
Study on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson’s Disease Patients with Motor Fluctuations

Not recruiting

3 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Carbidopa
- Levodopa
+3
Study of Atidarsagene Autotemcel for Treating Early Onset Metachromatic Leukodystrophy (MLD) in Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Metachromatic leukodystrophy
Investigated Drugs:
- Atidarsagene Autotemcel
Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study of Giredestrant for Patients with Grade 1 Endometrial Cancer

Not recruiting

2 1 1
Investigated Drugs:
- Giredestrant
Study on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington’s Disease

Not recruiting

2 1
Investigated Diseases:
- Huntington’s disease
Investigated Drugs:
- Tominersen
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies